{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:33:13Z","timestamp":1791253993819,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2019,6,15]]},"DOI":"10.1007\/s11938-019-00229-2","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T04:18:44Z","timestamp":1558671524000},"page":"254-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Infections in Cirrhosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Sirina","family":"Ekpanyapong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"9","key":"229_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","volume":"9","author":"AR Bonnel","year":"2011","unstructured":"Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clinical Gastroenterol Hepatol. 2011;9(9):727\u201338. https:\/\/doi.org\/10.1016\/j.cgh.2011.02.031.","journal-title":"Clinical Gastroenterol Hepatol"},{"issue":"3","key":"229_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/hep.21737","volume":"46","author":"RP Mookerjee","year":"2007","unstructured":"Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology. 2007;46(3):831\u201340. https:\/\/doi.org\/10.1002\/hep.21737.","journal-title":"Hepatology."},{"issue":"2","key":"229_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","volume":"42","author":"HE Wasmuth","year":"2005","unstructured":"Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghoner A, Vidacek D, Siewert E, et al. Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis. J Hepatol. 2005;42(2):195\u2013201. https:\/\/doi.org\/10.1016\/j.jhep.2004.10.019.","journal-title":"J Hepatol"},{"issue":"6","key":"229_CR4","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"R Jalan","year":"2014","unstructured":"Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310\u201324. https:\/\/doi.org\/10.1016\/j.jhep.2014.01.024.","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"229_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","volume":"56","author":"J Fernandez","year":"2012","unstructured":"Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol. 2012;56(Suppl 1):S1\u201312. https:\/\/doi.org\/10.1016\/S0168-8278(12)60002-6.","journal-title":"J Hepatol"},{"issue":"5","key":"229_CR6","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"J Fernandez","year":"2012","unstructured":"Fernandez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551\u201361. https:\/\/doi.org\/10.1002\/hep.25532.","journal-title":"Hepatology."},{"issue":"11","key":"229_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","volume":"8","author":"M Merli","year":"2010","unstructured":"Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8(11):979\u201385. https:\/\/doi.org\/10.1016\/j.cgh.2010.06.024.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"229_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fernandez","year":"2002","unstructured":"Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140\u20138. https:\/\/doi.org\/10.1053\/jhep.2002.30082.","journal-title":"Hepatology."},{"issue":"7","key":"229_CR9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426\u201337,37.e1\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.042.","journal-title":"Gastroenterology"},{"issue":"1","key":"229_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/hep.21443","volume":"45","author":"S Fasolato","year":"2007","unstructured":"Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology. 2007;45(1):223\u20139. https:\/\/doi.org\/10.1002\/hep.21443.","journal-title":"Hepatology."},{"issue":"Suppl 1","key":"229_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/liv.13645","volume":"38","author":"S Piano","year":"2018","unstructured":"Piano S, Brocca A, Mareso S, Angeli P. Infections complicating cirrhosis. Liver Int. 2018;38(Suppl 1):126\u201333. https:\/\/doi.org\/10.1111\/liv.13645.","journal-title":"Liver Int"},{"issue":"3","key":"229_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","volume":"124","author":"MG Foreman","year":"2003","unstructured":"Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest. 2003;124(3):1016\u201320.","journal-title":"Chest."},{"issue":"4","key":"229_CR13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139(4):1246\u201356,56.e1\u20135. https:\/\/doi.org\/10.1053\/j.gastro.2010.06.019.","journal-title":"Gastroenterology"},{"issue":"5","key":"229_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jhep.2016.08.006","volume":"65","author":"J Fernandez","year":"2016","unstructured":"\u2022 Fernandez J, Bert F, Nicolas-Chanoine MH. The challenges of multi-drug-resistance in hepatology. J Hepatol. 2016;65(5):1043\u201354. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.006A brief review of treatment strategies and global health crisis of antimicrobial resistance in cirrhosis.","journal-title":"J Hepatol"},{"issue":"1, supplement","key":"229_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.dld.2018.01.007","volume":"50","author":"S Piano","year":"2018","unstructured":"\u2022 Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, et al. Epidemiology, predictors and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world. Final results of the \u201cGlobal study\u201d. Digestive and Liver Disease. 2018;50(1, supplement):2\u20133. https:\/\/doi.org\/10.1016\/j.dld.2018.01.007A multicenter study of global prevalence and epidemiology of MDR bacterial infections in cirrhosis.","journal-title":"Digestive and Liver Disease"},{"issue":"6","key":"229_CR16","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"A Albillos","year":"2014","unstructured":"Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385\u201396. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.010.","journal-title":"J Hepatol"},{"issue":"5","key":"229_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4254\/wjh.v4.i5.158","volume":"4","author":"C Bunchorntavakul","year":"2012","unstructured":"Bunchorntavakul C, Chavalitdhamrong D. Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. World J Hepatol. 2012;4(5):158\u201368. https:\/\/doi.org\/10.4254\/wjh.v4.i5.158.","journal-title":"World J Hepatol"},{"issue":"5","key":"229_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.20524\/aog.2017.0178","volume":"30","author":"A Alexopoulou","year":"2017","unstructured":"Alexopoulou A, Agiasotelli D, Vasilieva LE, Dourakis SP. Bacterial translocation markers in liver cirrhosis. Ann Gastroenterol. 2017;30(5):486\u201397. https:\/\/doi.org\/10.20524\/aog.2017.0178.","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"229_CR19","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/hep.23918","volume":"52","author":"P Bellot","year":"2010","unstructured":"Bellot P, Garcia-Pagan JC, Frances R, Abraldes JG, Navasa M, Perez-Mateo M, et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology. 2010;52(6):2044\u201352. https:\/\/doi.org\/10.1002\/hep.23918.","journal-title":"Hepatology."},{"issue":"10","key":"229_CR20","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/00365520310004939","volume":"38","author":"R Sadik","year":"2003","unstructured":"Sadik R, Abrahamsson H, Bjornsson E, Gunnarsdottir A, Stotzer PO. Etiology of portal hypertension may influence gastrointestinal transit. Scand J Gastroenterol. 2003;38(10):1039\u201344.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"229_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","volume":"58","author":"T Reiberger","year":"2013","unstructured":"Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol. 2013;58(5):911\u201321. https:\/\/doi.org\/10.1016\/j.jhep.2012.12.011.","journal-title":"J Hepatol"},{"issue":"5","key":"229_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/hep.1840180520","volume":"18","author":"C Guarner","year":"1993","unstructured":"Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 1993;18(5):1139\u201343.","journal-title":"Hepatology."},{"key":"229_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","volume":"17","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, Vargas HE, Reddy KR, Lai JC, O'Leary JG, Tandon P, et al. Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis. Clin Gastroenterol Hepatol. 2018;17:756\u2013765.e3. https:\/\/doi.org\/10.1016\/j.cgh.2018.07.022.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"229_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2362.2011.02609.x","volume":"42","author":"SF Assimakopoulos","year":"2012","unstructured":"Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, Karatza E, Triantos C, Vagianos CE, et al. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Investig. 2012;42(4):439\u201346. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02609.x.","journal-title":"Eur J Clin Investig"},{"issue":"5","key":"229_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3748\/wjg.v5.i5.391","volume":"5","author":"O Saitoh","year":"1999","unstructured":"Saitoh O, Sugi K, Lojima K, Matsumoto H, Nakagawa K, Kayazawa M, et al. Increased prevalence of intestinal inflammation in patients with liver cirrhosis. World J Gastroenterol. 1999;5(5):391\u20136.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"229_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1053\/jhep.2003.50116","volume":"37","author":"V Lorenzo-Zuniga","year":"2003","unstructured":"Lorenzo-Zuniga V, Bartoli R, Planas R, Hofmann AF, Vinado B, Hagey LR, et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology. 2003;37(3):551\u20137. https:\/\/doi.org\/10.1053\/jhep.2003.50116.","journal-title":"Hepatology."},{"issue":"4","key":"229_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/hep.24789","volume":"55","author":"Z Teltschik","year":"2012","unstructured":"Teltschik Z, Wiest R, Beisner J, Nuding S, Hofmann C, Schoelmerich J, et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology. 2012;55(4):1154\u201363. https:\/\/doi.org\/10.1002\/hep.24789.","journal-title":"Hepatology."},{"issue":"10","key":"229_CR28","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.3748\/wjg.v20.i10.2542","volume":"20","author":"T Bruns","year":"2014","unstructured":"Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol. 2014;20(10):2542\u201354. https:\/\/doi.org\/10.3748\/wjg.v20.i10.2542.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"229_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-0036-1583202","volume":"36","author":"V Arroyo","year":"2016","unstructured":"Arroyo V, Jalan R. Acute-on-chronic liver failure: definition, diagnosis, and clinical characteristics. Semin Liver Dis. 2016;36(2):109\u201316. https:\/\/doi.org\/10.1055\/s-0036-1583202.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"229_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","volume":"66","author":"R Hernaez","year":"2017","unstructured":"Hernaez R, Sola E, Moreau R, Gines P. Acute-on-chronic liver failure: an update. Gut. 2017;66(3):541\u201353. https:\/\/doi.org\/10.1136\/gutjnl-2016-312670.","journal-title":"Gut."},{"issue":"6","key":"229_CR31","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/hep.29773","volume":"67","author":"JG O'Leary","year":"2018","unstructured":"O'Leary JG, Reddy KR, Garcia-Tsao G, Biggins SW, Wong F, Fallon MB, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67(6):2367\u201374. https:\/\/doi.org\/10.1002\/hep.29773.","journal-title":"Hepatology."},{"issue":"1","key":"229_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/hep.27077","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"\u2022\u2022 Bajaj JS, O'Leary JG, Reddy KR, Wong F, Biggins SW, Patton H, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60(1):250\u20136. https:\/\/doi.org\/10.1002\/hep.27077The study using NACSELD database on prevalence and survival of infection-related ACLF in hospitalized cirrhotic patients.","journal-title":"Hepatology"},{"issue":"7","key":"229_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/lt.24139","volume":"21","author":"K. Rajender Reddy","year":"2015","unstructured":"\u2022 Reddy KR, O\u2019Leary JG, Kamath PS, Fallon MB, Biggins SW, Wong F, et al. High risk of delisting or death in liver transplant candidates following infections: results from the North American Consortium for the Study of End-Stage Liver Disease. Liver Transpl. 2015;21(7):881\u20138. https:\/\/doi.org\/10.1002\/lt.24139The study using NACSELD database on prognosis of liver transplant candidates following infections.","journal-title":"Liver Transplantation"},{"issue":"4","key":"229_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/jhep.2003.50119","volume":"37","author":"LT Evans","year":"2003","unstructured":"Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. 2003;37(4):897\u2013901. https:\/\/doi.org\/10.1053\/jhep.2003.50119.","journal-title":"Hepatology."},{"issue":"1","key":"229_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142\u201353.","journal-title":"J Hepatol"},{"issue":"3","key":"229_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.annemergmed.2008.02.016","volume":"52","author":"B Chinnock","year":"2008","unstructured":"Chinnock B, Afarian H, Minnigan H, Butler J, Hendey GW. Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis. Ann Emerg Med. 2008;52(3):268\u201373. https:\/\/doi.org\/10.1016\/j.annemergmed.2008.02.016.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"229_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"EASL","year":"2018","unstructured":"\u2022\u2022 EASL. Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.024An updated EASL guideline and recommendations 2018 for bacterial infections in cirrhosis including both SBP and non-SBP infections.","journal-title":"J Hepatol"},{"issue":"2","key":"229_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/gutjnl-2011-300779","volume":"61","author":"R Wiest","year":"2012","unstructured":"Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012;61(2):297\u2013310. https:\/\/doi.org\/10.1136\/gutjnl-2011-300779.","journal-title":"Gut."},{"issue":"6","key":"229_CR39","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087\u2013107. https:\/\/doi.org\/10.1002\/hep.22853.","journal-title":"Hepatology."},{"issue":"5","key":"229_CR40","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/hep.21588","volume":"45","author":"JB Nousbaum","year":"2007","unstructured":"Nousbaum JB, Cadranel JF, Nahon P, Khac EN, Moreau R, Thevenot T, et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology. 2007;45(5):1275\u201381. https:\/\/doi.org\/10.1002\/hep.21588.","journal-title":"Hepatology."},{"issue":"3","key":"229_CR41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1053\/j.gastro.2008.05.045","volume":"135","author":"MA Parsi","year":"2008","unstructured":"Parsi MA, Saadeh SN, Zein NN, Davis GL, Lopez R, Boone J, et al. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology. 2008;135(3):803\u20137. https:\/\/doi.org\/10.1053\/j.gastro.2008.05.045.","journal-title":"Gastroenterology."},{"issue":"1","key":"229_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12876-016-0546-9","volume":"16","author":"SS Lee","year":"2016","unstructured":"Lee SS, Min HJ, Choi JY, Cho HC, Kim JJ, Lee JM, et al. Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis. BMC Gastroenterol. 2016;16(1):132. https:\/\/doi.org\/10.1186\/s12876-016-0546-9.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"229_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jhep.2011.06.025","volume":"56","author":"H Enomoto","year":"2012","unstructured":"Enomoto H, Inoue S, Matsuhisa A, Aizawa N, Imanishi H, Saito M, et al. Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitis. J Hepatol. 2012;56(1):85\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.025.","journal-title":"J Hepatol"},{"issue":"4","key":"229_CR44","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57(4):1651\u20133. https:\/\/doi.org\/10.1002\/hep.26359.","journal-title":"Hepatology."},{"issue":"1","key":"229_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/0003-4819-150-1-200901060-00005","volume":"150","author":"M Venditti","year":"2009","unstructured":"Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150(1):19\u201326.","journal-title":"Ann Intern Med"},{"issue":"3","key":"229_CR46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"229_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403\u20139. https:\/\/doi.org\/10.1056\/NEJM199908053410603.","journal-title":"N Engl J Med"},{"issue":"6","key":"229_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4254\/wjh.v8.i6.307","volume":"8","author":"C Bunchorntavakul","year":"2016","unstructured":"\u2022\u2022 Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: a critical review and practical guidance. World J Hepatol. 2016;8(6):307\u201321. https:\/\/doi.org\/10.4254\/wjh.v8.i6.307A detailed review of bacterial infections in cirrhosis.","journal-title":"World J Hepatol"},{"issue":"34","key":"229_CR49","doi-asserted-by":"publisher","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","volume":"64","author":"M Kobayashi","year":"2015","unstructured":"Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Weekly Rep. 2015;64(34):944\u20137. https:\/\/doi.org\/10.15585\/mmwr.mm6434a4.","journal-title":"MMWR Morb Mortal Weekly Rep"},{"issue":"Rr-16","key":"229_CR50","first-page":"1","volume":"55","author":"EE Mast","year":"2006","unstructured":"Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006;55(Rr-16):1\u201333quiz CE1\u20134.","journal-title":"MMWR Recomm Rep"},{"issue":"1 Pt 1","key":"229_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/hep.1840200107","volume":"20","author":"M Blaise","year":"1994","unstructured":"Blaise M, Pateron D, Trinchet JC, Levacher S, Beaugrand M, Pourriat JL. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1994;20(1 Pt 1):34\u20138.","journal-title":"Hepatology."},{"issue":"5","key":"229_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","volume":"34","author":"NC Chavez-Tapia","year":"2011","unstructured":"Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, Mendez-Sanchez N, Gluud C, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther. 2011;34(5):509\u201318. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04746.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"229_CR53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","volume":"131","author":"J Fernandez","year":"2006","unstructured":"Fernandez J, Ruiz del Arbol L, Gomez C, Durandez R, Serradilla R, Guarner C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131(4):1049\u201356;quiz 1285. https:\/\/doi.org\/10.1053\/j.gastro.2006.07.010.","journal-title":"Gastroenterology."},{"issue":"3","key":"229_CR54","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J Fernandez","year":"2007","unstructured":"Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology. 2007;133(3):818\u201324. https:\/\/doi.org\/10.1053\/j.gastro.2007.06.065.","journal-title":"Gastroenterology."},{"issue":"5","key":"229_CR55","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jhep.2008.01.024","volume":"48","author":"R Terg","year":"2008","unstructured":"Terg R, Fassio E, Guevara M, Cartier M, Longo C, Lucero R, et al. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. J Hepatol. 2008;48(5):774\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2008.01.024.","journal-title":"J Hepatol"},{"issue":"4 Pt 1","key":"229_CR56","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/hep.1840120416","volume":"12","author":"P Gines","year":"1990","unstructured":"Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12(4 Pt 1):716\u201324.","journal-title":"Hepatology."},{"issue":"4","key":"229_CR57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1055\/s-2007-1007209","volume":"17","author":"M Navasa","year":"1997","unstructured":"Navasa M, Rimola A, Rodes J. Bacterial infections in liver disease. Semin Liver Dis. 1997;17(4):323\u201333. https:\/\/doi.org\/10.1055\/s-2007-1007209.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"229_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/gut.25.2.133","volume":"25","author":"AK Burroughs","year":"1984","unstructured":"Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfitt W, Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut. 1984;25(2):133\u20137.","journal-title":"Gut."},{"issue":"6","key":"229_CR59","first-page":"380","volume":"10","author":"C Cruz Rde","year":"2006","unstructured":"Cruz Rde C, Tanajura D, Almeida D, Cruz M, Parana R. Urinary tract infection in non-hospitalized patients with cirrhosis and no symptoms of urinary tract infection: a case series study. Braz J Infect Dis. 2006;10(6):380\u20133.","journal-title":"Braz J Infect Dis"},{"issue":"4","key":"229_CR60","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.eururo.2006.08.012","volume":"51","author":"TE Bjerklund Johansen","year":"2007","unstructured":"Bjerklund Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P. Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol. 2007;51(4):1100\u201311;discussion 12. https:\/\/doi.org\/10.1016\/j.eururo.2006.08.012.","journal-title":"Eur Urol"},{"issue":"10","key":"229_CR61","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1046\/j.1198-743x.2001.00324.x","volume":"7","author":"E Bouza","year":"2001","unstructured":"Bouza E, San Juan R, Munoz P, Voss A, Kluytmans J. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect. 2001;7(10):532\u201342.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"229_CR62","first-page":"541","volume":"68","author":"E Jimenez-Alcaide","year":"2015","unstructured":"Jimenez-Alcaide E, Medina-Polo J, Garcia-Gonzalez L, Arrebola-Pajares A, Guerrero-Ramos F, Perez-Cadavid S, et al. Healthcare-associated urinary tract infections in patients with a urinary catheter: risk factors, microbiological characteristics and patterns of antibiotic resistance. Arch Esp Urol. 2015;68(6):541\u201350.","journal-title":"Arch Esp Urol"},{"issue":"Suppl 1","key":"229_CR63","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.ijantimicag.2007.07.033","volume":"31","author":"P Tenke","year":"2008","unstructured":"Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents. 2008;31(Suppl 1):S68\u201378. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.07.033.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"229_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"DM Sievert","year":"2013","unstructured":"Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34(1):1\u201314. https:\/\/doi.org\/10.1086\/668770.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"229_CR65","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1086\/667745","volume":"33","author":"AS Chitnis","year":"2012","unstructured":"Chitnis AS, Edwards JR, Ricks PM, Sievert DM, Fridkin SK, Gould CV. Device-associated infection rates, device utilization, and antimicrobial resistance in long-term acute care hospitals reporting to the National Healthcare Safety Network, 2010. Infect Control Hosp Epidemiol. 2012;33(10):993\u20131000. https:\/\/doi.org\/10.1086\/667745.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"229_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-230X-13-25","volume":"13","author":"TH Hung","year":"2013","unstructured":"Hung TH, Tseng CW, Hsieh YH, Tseng KC, Tsai CC, Tsai CC. High mortality of pneumonia in cirrhotic patients with ascites. BMC Gastroenterol. 2013;13:25. https:\/\/doi.org\/10.1186\/1471-230X-13-25.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"229_CR67","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/MD.0b013e318210504c","volume":"90","author":"D Viasus","year":"2011","unstructured":"Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J, et al. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine. 2011;90(2):110\u20138. https:\/\/doi.org\/10.1097\/MD.0b013e318210504c.","journal-title":"Medicine."},{"issue":"4","key":"229_CR68","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/01.mcg.0000248018.08515.f9","volume":"41","author":"R Cheruvattath","year":"2007","unstructured":"Cheruvattath R, Balan V. Infections in patients with end-stage liver disease. J Clin Gastroenterol. 2007;41(4):403\u201311. https:\/\/doi.org\/10.1097\/01.mcg.0000248018.08515.f9.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"229_CR69","first-page":"374","volume":"27","author":"RE Hamza","year":"2014","unstructured":"Hamza RE, Villyoth MP, Peter G, Joseph D, Govindaraju C, Tank DC, et al. Risk factors of cellulitis in cirrhosis and antibiotic prophylaxis in preventing recurrence. Ann Gastroenterol. 2014;27(4):374\u20139.","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"229_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.diagmicrobio.2008.05.016","volume":"62","author":"CC Lee","year":"2008","unstructured":"Lee CC, Chi CH, Lee NY, Lee HC, Chen CL, Chen PL, et al. Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial Gram-negative bacillary infections. Diagn Microbiol Infect Dis. 2008;62(2):219\u201325. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.05.016.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"229_CR71","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/S0168-8278(09)60008-8","volume":"50","author":"JG Acevedo","year":"2009","unstructured":"Acevedo JG, Fernandez J, Castro M, Garcia O, de Lope CR, Navasa M, et al. 6 current efficacy of recommended empirical antibiotic therapy in patients with cirrhosis and bacterial infection. J Hepatol. 2009;50:S5. https:\/\/doi.org\/10.1016\/S0168-8278(09)60008-8.","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"229_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11046-014-9825-6","volume":"179","author":"T Lahmer","year":"2015","unstructured":"Lahmer T, Messer M, Mayr U, Saugel B, Noe S, Schultheiss C, et al. Fungal \u201ccolonisation\u201d is associated with increased mortality in medical intensive care unit patients with liver cirrhosis. Mycopathologia. 2015;179(1\u20132):63\u201371. https:\/\/doi.org\/10.1007\/s11046-014-9825-6.","journal-title":"Mycopathologia."},{"issue":"3\u20134","key":"229_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11046-014-9740-x","volume":"177","author":"T Lahmer","year":"2014","unstructured":"Lahmer T, Messer M, Schwerdtfeger C, Rasch S, Lee M, Saugel B, et al. Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis. Mycopathologia. 2014;177(3\u20134):193\u20137. https:\/\/doi.org\/10.1007\/s11046-014-9740-x.","journal-title":"Mycopathologia."},{"issue":"4","key":"229_CR74","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jhep.2015.05.032","volume":"63","author":"A Alexopoulou","year":"2015","unstructured":"Alexopoulou A, Vasilieva L, Agiasotelli D, Dourakis SP. Fungal infections in patients with cirrhosis. J Hepatol. 2015;63(4):1043\u20135. https:\/\/doi.org\/10.1016\/j.jhep.2015.05.032.","journal-title":"J Hepatol"},{"issue":"4","key":"229_CR75","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/ajg.2017.471","volume":"113","author":"JS Bajaj","year":"2018","unstructured":"Bajaj JS, Rajender Reddy K, Tandon P, Wong F, Kamath PS, Biggins SW, et al. Prediction of fungal infection development and their impact on survival using the NACSELD cohort. Am J Gastroenterol. 2018;113(4):556\u201363. https:\/\/doi.org\/10.1038\/ajg.2017.471.","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"229_CR76","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","volume":"372","author":"MR Thursz","year":"2015","unstructured":"Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372(17):1619\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1412278.","journal-title":"N Engl J Med"},{"issue":"5","key":"229_CR77","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/liv.12939","volume":"36","author":"BS Hmoud","year":"2016","unstructured":"Hmoud BS, Patel K, Bataller R, Singal AK. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver Int. 2016;36(5):721\u20138. https:\/\/doi.org\/10.1111\/liv.12939.","journal-title":"Liver Int"},{"issue":"2","key":"229_CR78","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","volume":"60","author":"T Gustot","year":"2014","unstructured":"Gustot T, Maillart E, Bocci M, Surin R, Trepo E, Degre D, et al. Invasive aspergillosis in patients with severe alcoholic hepatitis. J Hepatol. 2014;60(2):267\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2013.09.011.","journal-title":"J Hepatol"},{"issue":"1","key":"229_CR79","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11894-012-0300-6","volume":"15","author":"MD Leise","year":"2013","unstructured":"Leise MD, Talwalkar JA. Immunizations in chronic liver disease: what should be done and what is the evidence. Curr Gastroenterol Rep. 2013;15(1):300. https:\/\/doi.org\/10.1007\/s11894-012-0300-6.","journal-title":"Curr Gastroenterol Rep"},{"issue":"19\u201320","key":"229_CR80","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/S0264-410X(03)00139-7","volume":"21","author":"PL Almasio","year":"2003","unstructured":"Almasio PL, Amoroso P. HAV infection in chronic liver disease: a rationale for vaccination. Vaccine. 2003;21(19\u201320):2238\u201341.","journal-title":"Vaccine."},{"issue":"Suppl 10A","key":"229_CR81","doi-asserted-by":"publisher","first-page":"21s","DOI":"10.1016\/j.amjmed.2005.07.013","volume":"118","author":"EB Keeffe","year":"2005","unstructured":"Keeffe EB. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med. 2005;118(Suppl 10A):21s\u20137s. https:\/\/doi.org\/10.1016\/j.amjmed.2005.07.013.","journal-title":"Am J Med"},{"issue":"8","key":"229_CR82","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/S0041-1345(02)03572-8","volume":"34","author":"GA Smallwood","year":"2002","unstructured":"Smallwood GA, Coloura CT, Martinez E, Stieber AC, Heffron TG. Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine? Transplant Proc. 2002;34(8):3289\u201390.","journal-title":"Transplant Proc"},{"issue":"1","key":"229_CR83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/jhep.2001.25883","volume":"34","author":"MR Arguedas","year":"2001","unstructured":"Arguedas MR, Johnson A, Eloubeidi MA, Fallon MB. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology. 2001;34(1):28\u201331. https:\/\/doi.org\/10.1053\/jhep.2001.25883.","journal-title":"Hepatology."},{"issue":"6","key":"229_CR84","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/j.1572-0241.1999.01150.x","volume":"94","author":"JA Dumot","year":"1999","unstructured":"Dumot JA, Barnes DS, Younossi Z, Gordon SM, Avery RK, Domen RE, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol. 1999;94(6):1601\u20134. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01150.x.","journal-title":"Am J Gastroenterol"},{"key":"229_CR85","doi-asserted-by":"publisher","first-page":"196704","DOI":"10.1155\/2013\/196704","volume":"2013","author":"DA Roni","year":"2013","unstructured":"Roni DA, Pathapati RM, Kumar AS, Nihal L, Sridhar K, Tumkur RS. Safety and efficacy of hepatitis B vaccination in cirrhosis of liver. Adv Virol. 2013;2013:196704\u20135. https:\/\/doi.org\/10.1155\/2013\/196704.","journal-title":"Adv Virol"},{"issue":"5","key":"229_CR86","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/lt.500040515","volume":"4","author":"EB Keeffe","year":"1998","unstructured":"Keeffe EB, Krause DS. Hepatitis B vaccination of patients with chronic liver disease. Liver Transpl Surg. 1998;4(5):437\u20139.","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"229_CR87","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s150100070002","volume":"28","author":"S Chlabicz","year":"2000","unstructured":"Chlabicz S, Grzeszczuk A. Hepatitis B virus vaccine for patients with hepatitis C virus infection. Infection. 2000;28(6):341\u20135.","journal-title":"Infection."},{"issue":"4","key":"229_CR88","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1590\/S1413-86702008000400009","volume":"12","author":"PR Bonazzi","year":"2008","unstructured":"Bonazzi PR, Bacchella T, Freitas AC, Osaki KT, Lopes MH, Freire MP, et al. Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list. Braz J Infect Dis. 2008;12(4):306\u20139.","journal-title":"Braz J Infect Dis"},{"issue":"5","key":"229_CR89","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0002-9629(15)40643-3","volume":"318","author":"JC Horlander","year":"1999","unstructured":"Horlander JC, Boyle N, Manam R, Schenk M, Herring S, Kwo PY, et al. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci. 1999;318(5):304\u20137.","journal-title":"Am J Med Sci"},{"issue":"12","key":"229_CR90","first-page":"1590","volume":"85","author":"W Carey","year":"1990","unstructured":"Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol. 1990;85(12):1590\u20132.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"229_CR91","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF01535747","volume":"33","author":"C Mendenhall","year":"1988","unstructured":"Mendenhall C, Roselle GA, Lybecker LA, Marshall LE, Grossman CJ, Myre SA, et al. Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci. 1988;33(3):263\u20139.","journal-title":"Dig Dis Sci"},{"key":"229_CR92","doi-asserted-by":"publisher","first-page":"5795712","DOI":"10.1155\/2016\/5795712","volume":"2016","author":"A Waghray","year":"2016","unstructured":"Waghray A, Waghray N, Khallafi H, Menon KV. Vaccinating adult patients with cirrhosis: trends over a decade in the United States. Gastroenterol Res Pract. 2016;2016:5795712\u20137. https:\/\/doi.org\/10.1155\/2016\/5795712.","journal-title":"Gastroenterol Res Pract"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-019-00229-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11938-019-00229-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-019-00229-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:18:56Z","timestamp":1744175936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11938-019-00229-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6,15]]}},"alternative-id":["229"],"URL":"https:\/\/doi.org\/10.1007\/s11938-019-00229-2","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"12 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sirina Ekpanyapong, MD, declares that she has no conflict of interest. K. Rajender Reddy, MD, declares that he has no conflict of interest for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}